Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits

Rivastigmine has been shown to improve cognition in HIV+ patients with minor neurocognitive disorders; however, the mechanisms underlying such beneficial effect are currently unknown. To assess whether rivastigmine therapy is associated with decreased brain inflammation and damage, we performed T1/T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Principais autores: Perrotta, Gaetano, Bonnier, Guillaume, Meskaldji, Djalel‐Eddine, Romascano, David, Aydarkhanov, Ruslan, Daducci, Alessandro, Simioni, Samanta, Cavassini, Matthias, Metral, Melanie, Lazeyras, François, Meuli, Reto, Krueger, Gunnar, Du Pasquier, Renaud A., Granziera, Cristina
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740253/
https://ncbi.nlm.nih.gov/pubmed/29296621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados